Overcoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategies

Russo, AlessandroCardona, Andrés F.Caglevic, ChristianManca, PaoloRuiz Patiño, AlejandroArrieta, OscarRolfo, Christian2021-05-212021-05-212020-122226-4477https://hdl.handle.net/20.500.12495/5891application/pdfengAttribution-NonCommercial-NoDerivatives 4.0 InternacionalOvercoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategiesArtículo de revistaAnaplastic lymphoma kinase (ALK)REarranged during Transfection (RET)C-ros protooncogene 1 (ROS1)Neurotrophic tyrosine receptor kinases (NTRK)Acquired resistancehttps://doi.org/10.21037/TLCR-2019-CNSCLC-06instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coOvercoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategiesAcceso abiertohttps://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abierto